Phytochemical fingerprinting, antioxidant activity and cytotoxic evaluation of marketed Thalictrum foliolosum (Pili Jadi) root against MCF-7 breast cancer cells Authors: Pragya Chettri, Atul Kaushik, Pradyumna Ghosal, Indra Manger, Mohammed Elfatih Hamida, Jeevan Jyoti Kaushik Published: 2026 ABSTRACT Breast cancer remains a major global health challenge, necessitating the exploration of safer and effective plant-derived therapeutics. Thalictrum foliolosum DC. (Pili Jadi), a medicinal herb widely used in Himalayan traditional medicine, is known to contain bioactive alkaloids and phenolic compounds with potential pharmacological properties. The present study investigated the phytochemical composition, antioxidant potential, HPTLC fingerprinting, and In-vitro cytotoxic activity of marketed T. foliolosum root extract against MCF-7 breast cancer cells. Preliminary phytochemical screening revealed the presence of alkaloids, flavonoids, phenolics, tannins, saponins, and terpenoids. The total phenolic content of the ethanolic root extract was determined as 16.80 ± 1.82 mg GAE/g dry weight using the Folin–Ciocalteu assay. Antioxidant activity evaluated by the DPPH radical scavenging assay demonstrated concentration-dependent activity, with the aqueous fraction exhibiting the strongest antioxidant potential (82% radical scavenging activity at 800 µg/mL; IC₅₀ = 313.5 µg/mL), followed by the ethyl acetate fraction. HPTLC fingerprinting confirmed the presence of characteristic phytochemical markers, including quercetin (Rf ≈ 0.51) and berberine (Rf ≈ 0.12). Cytotoxic evaluation using the MTT assay showed a mild dose-dependent reduction in MCF-7 cell viability, with 91.03% viability observed at 100 µg/mL and IC₅₀ > 100 µg/mL. The findings indicate that marketed T. foliolosum roots possess significant antioxidant phytochemicals and identifiable bioactive constituents supporting their traditional therapeutic claims. Further studies involving phytochemical isolation, mechanistic investigations, and in vivo validation are warranted to explore their full anticancer potential. Introduction Cancer represents one of the most significant global health challenges, accounting for nearly 10 million deaths annually worldwide. Among various malignancies, breast cancer remains the most commonly diagnosed cancer in women and a leading cause of cancer-related mortality globally1. According to recent global cancer statistics, breast cancer alone accounted for approximately 2.3 million new cases in 2022, emphasizing the urgent need for improved preventive and therapeutic strategies1,2. The growing burden of cancer strongly aligns with the objectives of the United Nations Sustainable Development Goals (SDGs), particularly Sustainable Development Goal-3, which aims to reduce premature mortality from non-communicable diseases through prevention, treatment, and the promotion of innovative healthcare approaches3,4. In this context, natural products and medicinal plants remain important sources for the discovery of novel therapeutic agents with improved safety and biological efficacy5. Medicinal plants have played a crucial role in traditional healthcare systems for centuries and continue to contribute significantly to modern pharmacotherapy6. It has been estimated that nearly 25–30% of currently available pharmaceutical drugs are derived directly or indirectly from natural products4,7. Plant-derived secondary metabolites such as alkaloids, flavonoids, phenolic acids, and terpenoids exhibit diverse pharmacological activities including antioxidant, antimicrobial, anti-inflammatory, and anticancer effects8. Despite the extensive traditional use of herbal medicines, many marketed herbal formulations lack rigorous scientific validation regarding their chemical composition, biological activity, and quality standards9. Therefore, systematic phytochemical and pharmacological investigations are essential to establish the authenticity, efficacy, and safety of such products9. Among the medicinal plants used in Himalayan traditional medicine, Thalictrum foliolosum DC., commonly known as Mamira, Pili Jari, or Indian Meadow Rue, is an important medicinal herb traditionally used in the Himalayan region10,11 for the treatment of inflammatory disorders, infections, and tumor-associated diseases, including breast cancer12. In Ayurvedic and folk medicine, the roots of this plant are valued for their blood-purifying, detoxifying, and anticancer properties12,13. Several herbal products marketed under the common names “Mamira” and “Pili Jari” are commercially utilized in traditional healthcare systems for immune enhancement and supportive management of chronic diseases13. The therapeutic significance of T. foliolosum is largely attributed to the presence of bioactive alkaloids such as berberine, palmatine, and jatrorrhizine, along with phenolic compounds possessing antioxidant and antiproliferative activities14,15. Previous pharmacological studies have reported that these phytoconstituents exhibit cytotoxic and apoptosis-inducing effects against different cancer cell lines, including breast cancer models15–18. These phytoconstituents are known to possess multiple pharmacological properties, including antioxidant and anticancer activities15. Berberine and related alkaloids have been widely studied for their ability to modulate cellular signaling pathways involved in tumor growth, apoptosis, and oxidative stress19. Oxidative stress plays a critical role in the pathogenesis of various chronic diseases, including cancer. Excessive production of reactive oxygen species (ROS) can cause oxidative damage to cellular components such as DNA, lipids, and proteins, ultimately contributing to carcinogenesis and tumor progression20. Antioxidants help neutralize ROS and protect cells from oxidative damage21, thereby reducing the risk of disease development. Consequently, the evaluation of antioxidant activity has become an important approach for identifying plant-derived compounds with potential chemo-preventive properties22. Among the various methods available, the DPPH radical scavenging assay is widely used for rapid screening of antioxidant potential in plant extracts and natural products23,24. Therefore, the traditional claims and increasing commercial utilization of T. foliolosum support its potential as a promising natural source for the development of phytopharmaceuticals targeting breast cancer and oxidative stress-related disorders. In addition to biological evaluation, chromatographic techniques are essential for the identification and quality assessment of herbal products. High-performance thin-layer chromatography (HPTLC) has emerged as a powerful analytical technique for the characterization and fingerprinting of phytochemical constituents in complex herbal matrices25. HPTLC allows simultaneous analysis of multiple samples, provides high resolution, and serves as an effective tool for standardization and quality control of medicinal plants and herbal formulations26. The development of reliable chromatographic fingerprints can therefore support the authentication and validation of marketed herbal products25,27. Although several studies28,29 have reported the pharmacological potential of Thalictrum foliolosum, systematic investigations focusing on the scientific validation of marketed root products (Fig. 1) remain limited. Considering the increasing global demand for plant-based therapeutics and the need for evidence-based validation of herbal medicines, comprehensive studies integrating phytochemical analysis and biological evaluation are required. Fig. 1Root of Marketed Thalictrum foliolosum. Root of Marketed Thalictrum foliolosum. Therefore, the present study aims to provide scientific validation of a marketed Thalictrum foliolosum (Pili Jadi) root preparation through integrated phytochemical screening, antioxidant evaluation, chromatographic fingerprinting using HPTLC, and In-vitro cytotoxic assessment against the MCF-7 breast cancer cells. The findings of this study are expected to generate valuable evidence supporting the therapeutic potential of T. foliolosum roots and contribute to the development of plant-based strategies for cancer research and sustainable healthcare solutions aligned with global health priorities. Results and discussion Yield percentage of Thalictrum foliolosum root extract The crude extract of Thalictrum foliolosum roots was subjected to solvent fractionation using solvents of increasing polarity, including hexane, chloroform, ethyl acetate, and water. The percentage yield of the obtained fractions is summarized in Fig. 2. The aqueous fraction showed the highest yield (40%), followed by ethyl acetate (15%), chloroform (12%), and hexane (10%). The higher recovery in the aqueous fraction indicates that the majority of phytoconstituents present in the root extract are polar in nature30. Similar observations have been reported for several medicinal plants where phenolic compounds and flavonoids are predominantly extracted in polar solvents28,29,31. The relatively low yield in the hexane fraction suggests a lower abundance of non-polar metabolites. Fig. 2Percentage Yield of Different Solvent Fractions Obtained from the Crude Extract. Percentage Yield of Different Solvent Fractions Obtained from the Crude Extract. Phytochemical screening Preliminary qualitative phytochemical analysis of the crude root extract revealed the presence of several bioactive secondary metabolites including alkaloids, flavonoids, saponins, tannins, triterpenoids, and phenolic compounds. These classes of compounds are widely known for their pharmacological activities such as antioxidant, antimicrobial, and anticancer effects. Further qualitative analysis of different solvent fractions showed variations in phytochemical distribution. The aqueous fraction exhibited a strong presence of flavonoids and terpenoids with moderate amounts of saponins. The ethyl acetate fraction showed moderate levels of alkaloids, tannins, and terpenoids along with the presence of flavonoids. The chloroform fraction contained alkaloids and terpenoids, while the hexane fraction mainly contained terpenoids. The presence of alkaloids and phenolics is particularly significant because Thalictrum species are known to contain benzylisoquinoline alkaloids such as Berberine which have been widely reported to possess antioxidant and anticancer properties. Quantification of total Phenolics content The total phenolic content (TPC) of the ethanolic extract of Thalictrum foliolosum roots was quantified using the Folin–Ciocalteu colorimetric assay with gallic acid as the reference standard. The extract exhibited a TPC value of 16.8 mg GAE/g dry weight (dw), indicating the presence of a considerable amount of phenolic phytoconstituents. The standard gallic acid calibration curve demonstrated a concentration-dependent increase in absorbance at 765 nm, confirming the accuracy and reliability of the assay method (Table 1). Table 1Quantification of total Phenolics content.S. No.Extract nameConcentrationTotal Phenolic Content(mg GAE per g of dry weight). 1 Ethanol1 mg/mL18.15 2 1 mg/mL14.73 3 1 mg/mL17.52 Mean ± SD 16.80 ± 1.82 Table 1Quantification of total Phenolics content.S. No.Extract nameConcentrationTotal Phenolic Content(mg GAE per g of dry weight). 1 Ethanol1 mg/mL18.15 2 1 mg/mL14.73 3 1 mg/mL17.52 Mean ± SD 16.80 ± 1.82 Quantification of total Phenolics content. In-vitro antioxidant activity Antioxidant activity of standard The antioxidant potential was evaluated using the DPPH radical scavenging assay with Ascorbic acid as the reference standard. The standard exhibited strong concentration-dependent radical scavenging activity, with percentage inhibition increasing from 43.14% at 20 µg/mL to 87.53% at 100 µg/mL. The IC₅₀ value for Ascorbic acid was calculated as 33.78 µg/mL, indicating strong antioxidant capacity (Table 2). Table 2The % Radical Scavenging Activity (%RSA) values for standard Ascorbic acid.Concentration%RSA20 µg/mL43.14%40 µg/mL53.10%60 µg/mL65.63%80 µg/mL77.13%100 µg/mL87.53%IC50=33.78 µg/mL. Table 2The % Radical Scavenging Activity (%RSA) values for standard Ascorbic acid.Concentration%RSA20 µg/mL43.14%40 µg/mL53.10%60 µg/mL65.63%80 µg/mL77.13%100 µg/mL87.53%IC50=33.78 µg/mL. The % Radical Scavenging Activity (%RSA) values for standard Ascorbic acid. IC50=33.78 µg/mL. Antioxidant activity of extract and fractions The antioxidant activity of the crude extract and its fractions was assessed at concentrations ranging from 200 to 800 µg/mL (Table 3). The crude extract exhibited moderate radical scavenging activity, increasing from 44% at 200 µg/mL to 68% at 800 µg/mL, with an IC₅₀ value of 371.42 µg/mL. Among the solvent fractions, the aqueous fraction demonstrated the strongest antioxidant activity with 82% radical scavenging activity at 800 µg/mL and an IC₅₀ value of 313.5 µg/mL. The ethyl acetate fraction also showed significant antioxidant potential, reaching 82% inhibition at the highest tested concentration with an IC₅₀ value of 493.3 µg/mL. In comparison, the chloroform fraction showed lower antioxidant activity (IC₅₀ = 840 µg/mL), while the hexane fraction demonstrated comparatively weak activity. The stronger antioxidant effect observed in the aqueous and ethyl acetate fractions may be attributed to the presence of phenolic compounds and flavonoids known for their free radical scavenging properties (Fig. 3). Fig. 3IC50 values of crude extract and its fractions. IC50 values of crude extract and its fractions. Table 3% Radical Scavenging Activity (%RSA) of crude extract and its fractions.Sample Extract200 µg/mL (RSA%)400 µg/mL (RSA%)600 µg/mL (RSA%)800 µg/mL (RSA%)IC50 (µg/mL)p-valueCrude extract44.0 ± 1.21e51.0 ± 1.36c57.5 ± 1.25c68.0 ± 1.32c371.42 ± 4.28c< 0.001Aqueous29.0 ± 1.18d66.5 ± 1.41d74.5 ± 1.33d82.0 ± 1.27d313.50 ± 3.71b< 0.001Ethyl acetate24.0 ± 1.06c29.0 ± 1.08b74.5 ± 1.29d82.0 ± 1.15d493.30 ± 4.63d< 0.001Chloroform18.0 ± 0.92b28.0 ± 1.02b38.0 ± 1.14b48.0 ± 1.28b840.00 ± 6.32e< 0.01Hexane10.0 ± 0.81a17.0 ± 0.87a23.0 ± 0.95a29.0 ± 1.03a> 800< 0.05 Table 3% Radical Scavenging Activity (%RSA) of crude extract and its fractions.Sample Extract200 µg/mL (RSA%)400 µg/mL (RSA%)600 µg/mL (RSA%)800 µg/mL (RSA%)IC50 (µg/mL)p-valueCrude extract44.0 ± 1.21e51.0 ± 1.36c57.5 ± 1.25c68.0 ± 1.32c371.42 ± 4.28c< 0.001Aqueous29.0 ± 1.18d66.5 ± 1.41d74.5 ± 1.33d82.0 ± 1.27d313.50 ± 3.71b< 0.001Ethyl acetate24.0 ± 1.06c29.0 ± 1.08b74.5 ± 1.29d82.0 ± 1.15d493.30 ± 4.63d< 0.001Chloroform18.0 ± 0.92b28.0 ± 1.02b38.0 ± 1.14b48.0 ± 1.28b840.00 ± 6.32e< 0.01Hexane10.0 ± 0.81a17.0 ± 0.87a23.0 ± 0.95a29.0 ± 1.03a> 800< 0.05 % Radical Scavenging Activity (%RSA) of crude extract and its fractions. HPTLC analysis High-performance thin-layer chromatography (HPTLC) was performed to establish the phytochemical fingerprint of the crude extract of Thalictrum foliolosum roots. Standard compounds including Quercetin, rutin, gallic acid, and berberine were used for comparison. The standard quercetin showed an Rf value of 0.515 ± 0.037, whereas berberine exhibited an Rf value of 0.125 ± 0.026. The chromatogram of the crude extract displayed multiple bands indicating the presence of diverse phytochemical constituents. The detection of bands corresponding to flavonoids and alkaloids suggests that these compounds may contribute to the biological activities observed in this study. HPTLC fingerprinting thus provides a reliable analytical tool for the identification and quality control of marketed Thalictrum foliolosum root products. The graph displays the peak of Rutin, a flavonoid known for its antioxidant properties, with absorbance. A distinct peak observed at RF ≈ 0.11 falls within the reference range for Berberine (RF = 0.125 ± 0.026). This alignment indicates a high probability of Berberine presence in the crude extract of T. foliolosum root. Berberine is an isoquinoline alkaloid known for its antimicrobial and anti-inflammatory properties, often used as a phytochemical marker in TLC-based plant profiling.A peak detected at RF ≈ 0.51 aligns closely with the reference range for Quercetin (RF = 0.515 ± 0.037). This suggests the possible presence of quercetin; a flavonoid commonly associated with antioxidant and anti-inflammatory activities. Its detection supports the potential bioactivity of the T. foliolosum root extract (Table 4; Fig. 4). HPTLC overlay densitogram analysis The overlay densitogram represents the comparative HPTLC fingerprint profiles of standard compounds (A–D) and the crude root extract of Thalictrum foliolosum scanned at 254 nm. The chromatographic profiles were evaluated based on retention factor (Rf) values, peak intensity, and densitometric distribution patterns. The overlay chromatogram demonstrated multiple resolved peaks in the crude extract, indicating the presence of diverse phytochemical constituents. Several peaks observed in the crude extract corresponded closely with the Rf values of standard compounds, suggesting chromatographic similarity and the possible occurrence of structurally related bioactive compounds. A major intense peak was observed around Rf ≈ 0.48, which showed strong correspondence with Standard Compound A and partial similarity with Standards B and C. This peak exhibited high absorbance intensity, indicating the abundance of a major phytoconstituent in the crude extract. Similarly, peaks in the lower Rf region (Rf 0.10–0.30) showed overlapping migration behavior with Standards B and C, indicating the presence of moderately polar phytochemicals. Broad peaks observed in the higher Rf region (Rf 0.72–0.92) displayed similarity with Standard Compound D, suggesting the occurrence of additional secondary metabolites.The crude extract chromatogram exhibited broader and more complex peak patterns compared to the individual standards due to the presence of multiple phytoconstituents in the plant extract. The similarity in densitometric patterns, including peak shape, migration distance, and absorbance response, supports the presence of compounds with comparable chromatographic behavior (Fig. 5). The overlay densitogram therefore confirms the phytochemical complexity of the extract and demonstrates the usefulness of HPTLC fingerprinting as a reliable tool for phytochemical profiling, standardization, authentication, and quality control of Thalictrum foliolosum root extracts. Fig. 4HPTLC Chromatogram of Thalictrum foliolosum roots extract. Chromatograms represent HPTLC fingerprint analysis with absorbance (AU) plotted against retention factor (RF). A Quercetin standard. B Rutin standard. C Gallic acid standard. D Berberine standard. E Crude Aq. extract (Fingerprint). HPTLC Chromatogram of Thalictrum foliolosum roots extract. Chromatograms represent HPTLC fingerprint analysis with absorbance (AU) plotted against retention factor (RF). A Quercetin standard. B Rutin standard. C Gallic acid standard. D Berberine standard. E Crude Aq. extract (Fingerprint). Fig. 5Schematic overlay densitogram* representing comparative HPTLC fingerprint profiles of standard compounds and crude extract of Thalictrum foliolosum. (*generative AI assisted - is a representative comparative illustration and not a direct raw instrumental output.) Schematic overlay densitogram* representing comparative HPTLC fingerprint profiles of standard compounds and crude extract of Thalictrum foliolosum. (*generative AI assisted - is a representative comparative illustration and not a direct raw instrumental output.) Table 4HPTLC Analysis of crude extract of marketed T. foliolosum roots.TrackVial IdVolumeRF valueType1Querecetin3.00.515+/- 0.037Reference2Rutin3.0-Reference3Gallic acid3.0-Reference4Berberine4.00.125+/0.026Reference5Crude extract of T.foliolosum root4.0N/ASample Table 4HPTLC Analysis of crude extract of marketed T. foliolosum roots.TrackVial IdVolumeRF valueType1Querecetin3.00.515+/- 0.037Reference2Rutin3.0-Reference3Gallic acid3.0-Reference4Berberine4.00.125+/0.026Reference5Crude extract of T.foliolosum root4.0N/ASample HPTLC Analysis of crude extract of marketed T. foliolosum roots. In-vitro anticancer activity The anticancer potential of the crude extract was evaluated using the MTT assay against the human breast cancer cell line MCF-7. The MTT assay measures cellular metabolic activity as an indicator of cell viability and cytotoxicity by reduction of MTT to formazan crystals in metabolically active cells. The cells were treated with different concentrations of the extract (6.25–100 µg/mL) and the percentage cell viability was determined (Table 2 of the report). The results showed a dose-dependent but relatively mild reduction in cell viability. At the lowest concentration of 6.25 µg/mL, the percentage viability was 99.77%, indicating negligible cytotoxic effect. With increasing concentration, cell viability gradually decreased to 99.08% at 12.5 µg/mL, 97.73% at 25 µg/mL, and 96.54% at 50 µg/mL. The highest tested concentration (100 µg/mL) showed the maximum cytotoxic effect with 91.03% cell viability. Since the cell viability remained above 50% even at the highest tested concentration, the IC₅₀ value could not be calculated under the tested conditions and was therefore reported as IC₅₀ > 100 µg/mL (Fig. 6). This suggests that the crude extract exhibits low cytotoxicity toward MCF-7 breast cancer cells at the tested concentrations. The observed mild cytotoxic activity may be attributed to the presence of phytochemicals such as alkaloids and flavonoids identified in the phytochemical screening. Although the crude extract demonstrated limited cytotoxicity. The present investigation was primarily designed as a preliminary screening study to validate and evaluate the phytochemical, antioxidant, and anticancer potential of the extract. Therefore, advanced characterization techniques such as LC-MS/MS, HPLC, and NMR were not included at this stage. Detailed phytochemical isolation and structural elucidation studies may be considered in future investigations to identify and characterize the specific bioactive constituents responsible for the observed biological activities. Fig. 6Morphological changes and MTT assay-based cytotoxic evaluation of Thalictrum foliolosum root extract against MCF-7 breast cancer cells. Representative phase-contrast micrographs showing morphological changes in MCF-7 cells following treatment with different concentrations of the extract: a Control (0 µg/mL), b 6.25 µg/mL, c 12.5 µg/mL, d 25 µg/mL, e 50 µg/mL, and f 100 µg/mL. Untreated control cells exhibited normal adherent morphology and dense cellular distribution, whereas treated cells showed gradual reduction in cell density, altered morphology, and partial detachment with increasing concentration. g Representative multi-well MTT assay plate of MCF-7 cells showing concentration-dependent variation in purple formazan formation, where darker purple coloration indicates higher metabolic activity and viable cells. Morphological changes and MTT assay-based cytotoxic evaluation of Thalictrum foliolosum root extract against MCF-7 breast cancer cells. Representative phase-contrast micrographs showing morphological changes in MCF-7 cells following treatment with different concentrations of the extract: a Control (0 µg/mL), b 6.25 µg/mL, c 12.5 µg/mL, d 25 µg/mL, e 50 µg/mL, and f 100 µg/mL. Untreated control cells exhibited normal adherent morphology and dense cellular distribution, whereas treated cells showed gradual reduction in cell density, altered morphology, and partial detachment with increasing concentration. g Representative multi-well MTT assay plate of MCF-7 cells showing concentration-dependent variation in purple formazan formation, where darker purple coloration indicates higher metabolic activity and viable cells. Materials and methods Chemicals and reagents All chemicals and reagents used in the present study were of analytical grade. Solvents and reagents were procured from Merck, Sisco Research Laboratories, and Rankem, India. Laboratory glassware and consumables were obtained from Borosil. Collection and procurement of the plant material Roots of T. foliolosum were procured from a commercial herbal supplier.Since the sample was commercially available, the same plant material used in the study was deposited in the Department of Botany, Sardar Bhagwan Singh University, Dehradun, India, as a voucher specimen for future reference and record maintenance under voucher specimen number PCOG/TFR-2025-03. Processing of the plant material The plant material was cleaned to remove adhering soil and impurities, followed by shade drying at room temperature to preserve thermolabile phytochemicals. The dried roots were coarsely powdered using a mortar and pestle under controlled temperature conditions32. The powdered material was passed through an 80-mesh sieve to ensure uniform particle size distribution. The sieved powder was stored in clean, airtight containers protected from light and moisture until further use33. Preparation of plant extract The powdered root material was subjected to maceration extraction using a hydroalcoholic solvent system consisting of 70% methanol and 30% distilled water13. The plant powder was immersed in the solvent mixture and kept under occasional stirring for efficient extraction of phytoconstituents. After extraction, the mixture was filtered using Whatman filter paper, and the filtrate was collected in clean labelled containers. The solvent was removed under reduced pressure using a rotary evaporator, which allowed gentle evaporation of the solvent at controlled temperature conditions to prevent degradation of thermolabile compounds33. The resulting concentrated extract was further desiccated and weighed to determine the extraction yield34,35. The percentage yield of the extract was calculated using the following formula:\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$Yield{\text{ }}\left( \% \right){\text{ }} = {\text{ }}\left( {Weight{\text{ }}of{\text{ }}extract{\text{ }}obtained{\text{ }}/{\text{ }}Weight{\text{ }}of{\text{ }}plant{\text{ }}material{\text{ }}used} \right) \times 100$$\end{document} The dried crude extract was stored in airtight glass containers at controlled temperature and protected from light for further experimental analysis. Preliminary phytochemical screening The hydroalcoholic extract of Thalictrum foliolosum roots was subjected to qualitative phytochemical screening to detect the presence of major classes of secondary metabolites. Standard phytochemical tests were performed to identify the presence of alkaloids, flavonoids, tannins, phenolic compounds, saponins, steroids, carbohydrates, proteins, and fats following previously reported procedures36. These phytochemical analyses provide an initial indication of the bioactive constituents responsible for the pharmacological activity of the plant extract. Liquid–liquid fractionation Liquid–liquid partitioning was carried out to separate phytoconstituents based on their polarity differences. The crude extract was first dissolved in 10 mL of distilled water with mild heating to facilitate complete dissolution. The aqueous solution was then transferred to a separating funnel and extracted with 15 mL of hexane to obtain a non-polar fraction. The hexane layer was separated, and the aqueous phase was re-extracted with fresh hexane to ensure maximum recovery of non-polar compounds37,38.Subsequently, the remaining aqueous phase was successively partitioned using ethyl acetate and chloroform (20 mL each) to isolate moderately polar phytoconstituents. Each fraction was concentrated using a rotary evaporator, dried, and weighed to determine the percentage yield of each fraction38. High-performance thin layer chromatography (HPTLC) analysis Chromatographic analysis of the crude extract was performed using High-Performance Thin Layer Chromatography (HPTLC). Pre-coated silica gel plates (100 × 100 mm, silica gel 60 F254, Merck) were used as the stationary phase. Samples prepared in methanol were applied as 8 mm bands using a CAMAG Linomat 5 applicator at a dosage speed of 150 nL/s with a pre-dosage volume of 0.20 µL. Chromatographic development was carried out up to a 70 mm solvent front using an appropriate mobile phase system. After development, the plates were analyzed using a CAMAG TLC Scanner in absorbance mode at 254 nm, using a deuterium lamp as the radiation source. Spectral scanning was further performed in the range of 254–459 nm to evaluate peak characteristics. Reference spectra were recorded at Y = 10 mm for each track, and peak purity analysis was performed to confirm analyte specificity. Instrument diagnostics were validated before and during analysis to ensure accurate chromatographic measurements39. The retention factor (Rf) values of the separated components were calculated and compared with those of reference standards including quercetin, rutin, gallic acid, and berberine to facilitate tentative identification of phytoconstituents.The obtained chromatographic profile served as a chemical fingerprint for the standardization and quality evaluation of the crude extract of Thalictrum foliolosum40. Determination of total phenolics content and antioxidant activity Determination of total phenolic content (TPC) The Total Phenolics Content (TPC) of the ethanolic root extract of Thalictrum foliolosum was determined using the Folin–Ciocalteu colorimetric method with slight modifications41,42. Gallic acid was used as the reference standard, and the results were expressed as milligrams of gallic acid equivalents per gram of extract (mg GAE/g) . Preparation of standard solution A stock solution of gallic acid was prepared and diluted to obtain concentrations of 10, 20, 30, 40, and 50 µg/mL. The absorbance of each concentration was recorded at 765 nm using a UV–Visible spectrophotometer after reaction with Folin–Ciocalteu reagent. Preparation of sample solution The ethanolic extract of Thalictrum foliolosum roots was prepared at a concentration of 1 mg/mL. An aliquot of the extract solution was mixed with Folin–Ciocalteu reagent followed by sodium carbonate solution. The reaction mixture was incubated at room temperature for 30 min in dark conditions for color development. The absorbance of the resulting blue-colored complex was measured at 765 nm against a reagent blank. All experiments were carried out in triplicate. The total phenolic content was calculated using the gallic acid calibration curve and expressed as mg GAE/g of extract. DPPH free radical scavenging assay The antioxidant activity of the crude extract and its solvent fractions of Thalictrum foliolosum roots was evaluated using the 2,2-diphenyl-1-picrylhydrazyl (DPPH) free radical scavenging assay, a widely used method for assessing the hydrogen-donating ability of plant extracts43. A 0.1 mM DPPH solution was prepared in methanol and stored in a dark container to prevent photo degradation. Different concentrations of the crude extract and its fractions were prepared in methanol. For each test sample, 2 mL of extract solution at various concentrations was mixed with 2 mL of DPPH solution in separate test tubes. A control solution was prepared by mixing 2 mL of methanol with 2 mL of DPPH solution without plant extract. Ascorbic acid was used as the reference standard antioxidant for comparison20.The reaction mixtures were incubated in the dark at room temperature for 30–120 min to allow complete interaction between the antioxidant compounds and DPPH radicals. After incubation, the absorbance of each mixture was measured at 517 nm using a UV–Visible spectrophotometer43. The ability of the extracts to scavenge DPPH free radicals was calculated as the percentage radical scavenging activity (%RSA) using the following equation: \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\% {\text{ }}Radical{\text{ }}Scavenging{\text{ }}Activity{\text{ }} = {\text{ }}(Ac\, - \,As)/Ac \times 100\backslash \%$$\end{document} Where: Ac = absorbance of the control and As = absorbance of the sample. A plot of percentage radical scavenging activity versus extract concentration was constructed to determine the antioxidant efficiency of the samples. The IC₅₀ value, defined as the concentration of extract required to inhibit 50% of DPPH free radicals, was calculated from the dose–response curve using linear interpolation between two concentrations surrounding 50% inhibition. Lower IC₅₀ values indicate higher antioxidant potential of the tested extract or fraction44. Statistical analysis All experiments were conducted in triplicate, and the results were presented as mean ± standard deviation (SD). Ascorbic acid was used as the reference standard for antioxidant activity. Statistical analysis and IC₅₀ values for the antioxidant activity of the plant extracts were determined using one-way ANOVA, and the data were expressed as mean ± standard deviation. The ANOVA results showed a statistically significant difference among the groups, with an F-value of 3.3906 and a p-value of 0.036417. A p-value less than 0.05 (p < 0.05) was considered statistically significant45,46. In-vitro anti-breast cancer activity MTT cytotoxicity assay Principle The cytotoxic activity of the crude extract was evaluated using the MTT assay, a widely used colorimetric method for determining cell viability, proliferation, and cytotoxicity. The assay is based on the reduction of the yellow tetrazolium salt 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) into purple formazan crystals by metabolically active cells. Viable cells contain NAD(P)H-dependent oxidoreductase enzymes, which convert MTT to insoluble formazan crystals. The crystals are subsequently dissolved using dimethyl sulfoxide (DMSO), producing a purple-colored solution whose absorbance is measured at 570 nm using a microplate reader. The intensity of the color is directly proportional to the number of viable cells47,48. Cell line and culture conditions The MCF-7 human breast cancer cell line was procured from the National Centre for Cell Sciences (NCCS), Pune, India. Cells were cultured in Dulbecco’s Modified Eagle Medium (DMEM) supplemented with: I.10% heat-inactivated fetal bovine serum (FBS).II.1% antibiotic cocktail containing. Penicillin (100 U/mL).Streptomycin (0.1 mg/mL).Amphotericin B (0.25 µg/mL). I.10% heat-inactivated fetal bovine serum (FBS). 10% heat-inactivated fetal bovine serum (FBS). II.1% antibiotic cocktail containing. Penicillin (100 U/mL).Streptomycin (0.1 mg/mL).Amphotericin B (0.25 µg/mL). 1% antibiotic cocktail containing. Penicillin (100 U/mL).Streptomycin (0.1 mg/mL).Amphotericin B (0.25 µg/mL). Penicillin (100 U/mL). Penicillin (100 U/mL). Streptomycin (0.1 mg/mL). Streptomycin (0.1 mg/mL). Amphotericin B (0.25 µg/mL). Amphotericin B (0.25 µg/mL). The cells were maintained in 25 cm² tissue culture flasks and incubated at 37 °C in a humidified atmosphere with 5% CO₂ using a Galaxy® 170 CO₂ incubator (Eppendorf, Germany). Experimental procedure Exponentially growing cells were seeded in 96-well microtiter plates at a density of 1 × 10⁴ cells per well and allowed to acclimatize for 24 h at 37 °C and 5% CO₂.The test extract was initially dissolved in DMSO (10 mg/mL) and sterilized using a 0.2 μm Millipore syringe filter. The stock solution was further diluted with DMEM medium to obtain final concentrations I.e. 6.25 µg/mL, 12.5 µg/mL, 25 µg/mL, 50 µg/mL, 100 µg/mL. These concentrations were added to the wells containing cultured cells. Untreated wells containing only culture medium served as the control.All treatments were performed in triplicate to ensure reproducibility. The plates were incubated for 24 h following treatment48. MTT assay After the treatment period, the culture medium was carefully aspirated and 100 µL of MTT solution (0.5 mg/mL in PBS) was added to each well. The plates were incubated for 2 h to allow the formation of formazan crystals.Following incubation, the supernatant was removed and 100 µL of 100% DMSO was added to dissolve the formazan crystals. The absorbance was measured at 570 nm using a microplate reader, with three wells without cells serving as blank controls48. Calculation of cell viability The percentage of cell viability was calculated using the following equation: Cell Viability (%)=Absorbance of treated cells/Absorbance of control cells×100. The percentage inhibition of cell growth was determined as:\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$Growth{\text{ }}Inhibition{\text{ }}\left( \% \right)\, = \,100\, - \,Cell{\text{ }}Viability{\text{ }}\left( \% \right)$$\end{document} Determination of IC₅₀ The IC₅₀ value, defined as the concentration of the extract required to inhibit 50% of cell viability, was determined by plotting the absorbance values obtained at different concentrations (6.25–100 µg/mL). The IC₅₀ value was calculated using the linear regression equation (y = mx + c) generated in Microsoft Excel48. Cell morphology Changes in cell morphology following treatment were observed and documented using an inverted phase-contrast microscope (LABOMED TCM 400, USA). Representative photomicrographs of each experimental group were captured at 10× magnification, corresponding to a total magnification of 100 × (10× objective × 10× ocular lens)49. Conclusion The present study provides preliminary scientific validation of the marketed roots of Thalictrum foliolosum DC. (Pili Jadi), a traditionally used Himalayan medicinal plant with emerging pharmacological significance. The extract demonstrated notable antioxidant activity, suggesting the presence of bioactive phytochemicals capable of scavenging free radicals and reducing oxidative stress, which is a key factor in cancer development. HPTLC fingerprint profiling further supported the occurrence of characteristic phytochemical markers, including berberine- and quercetin-like compounds.The novelty of the study lies in the phytochemical and biological evaluation of commercially available T. foliolosum root material, highlighting the importance of quality validation and scientific authentication of marketed herbal products widely used in traditional medicine. The observed antioxidant and cytotoxic activities are consistent with previously reported findings on the alkaloidal and phenolic richness of T. foliolosum and related species reported by earlier researchers50,51. Overall, the findings support the traditional therapeutic claims associated with T. foliolosum and emphasize the need for further advanced phytochemical characterization, mechanistic studies, and in vivo investigations to establish its potential as a natural antioxidant and anticancer phytopharmaceutical candidate. Limitations of the Study Due to laboratory and resource limitations, standard drug (positive control) for MTT assay could not be performed during the present study period. Confirmatory analytical characterization using advanced techniques such as LC–MS/MS, HPLC, or NMR was not performed and remains within the scope of future investigations to enable precise identification and structural validation of bioactive constituents.